How Peptides Are Administered: Routes, Bioavailability, and Why It Matters

Why Administration Route Matters

How a peptide enters the body determines whether it works at all. Unlike conventional small-molecule drugs (aspirin, ibuprofen, most oral medications), peptides are fragile chains of amino acids that are rapidly broken down by digestive enzymes and have difficulty crossing biological membranes. This makes the route of administration one of the most important practical considerations for any peptide.

This page explains why most peptides require injection, what the alternatives are, and the concept of bioavailability that underlies these constraints.

Who this page is for, and who it isn’t for

This page is for anyone new to peptides who wants to understand why administration routes differ across compounds. It is a reference page, not an instruction manual for self-injection. Medical procedures should be performed under the guidance of a qualified healthcare provider.

What Is Bioavailability?

Bioavailability refers to the fraction of an administered substance that reaches systemic circulation in an active form. A drug with 100% bioavailability (such as one given intravenously) delivers its full dose to the bloodstream. A drug with 5% oral bioavailability delivers only 5% of the swallowed dose to the bloodstream — the other 95% is destroyed during digestion or first-pass liver metabolism.

For most peptides, oral bioavailability is extremely low — often below 1–2%. This is the fundamental reason most peptides cannot simply be swallowed as pills.

Why Most Peptides Cannot Be Taken Orally

The gastrointestinal tract is designed to break proteins and peptides into individual amino acids for absorption. This is nutritionally useful but pharmacologically destructive.

Three barriers work against oral peptide delivery:

Enzymatic degradation. Pepsin in the stomach, trypsin and chymotrypsin in the small intestine, and brush border peptidases all cleave peptide bonds. A peptide swallowed as a capsule encounters these enzymes before it can reach the bloodstream.

Acidic environment. Stomach pH of 1.5–3.5 can denature peptide structures, altering their shape and function before enzymatic breakdown even begins.

Poor membrane permeability. Even if a peptide survived digestion intact, most peptides are too large and too hydrophilic (water-loving) to cross the intestinal epithelium efficiently. Small-molecule drugs (typically under 500 daltons) cross membranes readily. Most peptides are 500–5,000+ daltons.

The result: swallowing most research peptides would destroy them before they could act.

Subcutaneous Injection: The Primary Route

Subcutaneous (SC or “subQ”) injection delivers peptides into the fat layer beneath the skin, where they are absorbed into the bloodstream through surrounding capillaries. This is the most common route of administration for peptides in both clinical and research contexts.

Why subcutaneous works for peptides:

• Bypasses the digestive system entirely
• Provides relatively consistent absorption rates
• Simpler and safer than intravenous injection
• Can be self-administered (insulin has been given subcutaneously by patients for decades)

Typical injection sites include the lower abdomen (avoiding the navel), outer thigh, and upper arm. Rotation of injection sites helps prevent local tissue irritation.

FDA-approved peptide medications — semaglutide (Ozempic/Wegovy), tesamorelin (Egrifta), bremelanotide (PT-141) — are all administered subcutaneously. This is also the route described in virtually all research protocols for peptides like BPC-157, ipamorelin, and TB-500.

Other Routes of Administration

Intranasal. Some peptides are administered as nasal sprays. Selank and Semax are approved in Russia as nasal formulations. The nasal mucosa offers a thin epithelial barrier and rich blood supply, and some peptides can cross into systemic or even central nervous system circulation via this route. Bioavailability is lower than injection but higher than oral for many peptides.

Topical. GHK-Cu is one of the few peptides with clinical evidence for topical application, used in skincare for wound healing and anti-aging. Topical delivery limits the peptide’s effects to local tissue — useful for skin applications but not for systemic effects.

Oral (rare exceptions). MK-677 (ibutamoren) is orally active because it is not technically a peptide — it is a non-peptidyl small molecule that mimics ghrelin. Rybelsus (oral semaglutide) achieves oral bioavailability through co-formulation with an absorption enhancer (SNAC) that protects the peptide and promotes transcellular absorption. These are exceptions that prove the general rule.

Intravenous. Used primarily in clinical research settings. Provides 100% bioavailability but requires medical administration and carries higher risk of adverse reactions.

The Practical Implication

When evaluating any peptide, understanding its route of administration provides immediate practical context. A peptide sold as an oral capsule should raise questions: is it actually a peptide? Does it have evidence for oral bioavailability? Has its oral form been specifically studied?

For the vast majority of peptides discussed on this site, subcutaneous injection is the studied route. Claims about alternative delivery methods should be evaluated against the specific compound’s pharmacological properties and available evidence.

For guidance on evaluating peptide claims broadly, see how to read peptide claims critically. For an introduction to what peptides are and how they function, see what are peptides.

Related Articles

Peptide

GHK-Cu (Copper Peptide): Research, Mechanism, and Evidence for Tissue Repair

An evidence-based review of GHK-Cu — the naturally occurring copper tripeptide studied for wound healing, skin aging, and gene expression modulation. What the research shows.

Peptide

MK-677 (Ibutamoren): What the Research Shows About This Oral GH Secretagogue

An evidence-based review of MK-677 (ibutamoren) — clinical data on growth hormone secretion, body composition, sleep, and safety considerations.

Peptide

Selank: Research, Mechanism, and Clinical Evidence for Anxiety and Cognition

An evidence-based review of Selank — the tuftsin-derived heptapeptide studied for anxiolytic and nootropic effects. Russian clinical data, mechanism of action, and what is known.